Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antidepressant Treatment Response”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT06025474
What this trial is testing

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Who this might be right for
Burning Mouth Syndrome
Federico II University 203
Post-approval studies (Phase 4)Study completedNCT02058693
What this trial is testing

Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy

Who this might be right for
Major Depressive Disorder
Rush University Medical Center 41
Not applicableStudy completedNCT00289523
What this trial is testing

EEG Biomarkers for Predicting Response to Antidepressant Therapy

Who this might be right for
Major Depressive Disorder
Medtronic - MITG 375
Testing effectiveness (Phase 2)Ended earlyNCT02192099
What this trial is testing

Open Label Extension for GLYX13-C-202, NCT01684163

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 61
Not applicableStudy completedNCT00456014
What this trial is testing

Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment

Who this might be right for
Depression
New York State Psychiatric Institute 37
Post-approval studies (Phase 4)Study completedNCT00892463
What this trial is testing

Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Sunnybrook Health Sciences Centre 26
Testing effectiveness (Phase 2)Study completedNCT01500200
What this trial is testing

Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 142
Large-scale testing (Phase 3)Study completedNCT03739203
What this trial is testing

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Who this might be right for
Major Depressive Disorder
AbbVie 752
Large-scale testing (Phase 3)Study completedNCT05455684
What this trial is testing

Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 513
Large-scale testing (Phase 3)Study completedNCT01152554
What this trial is testing

Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderMDDDepression
AstraZeneca 813
Not applicableStudy completedNCT01446692
What this trial is testing

Badalona Major Depressive Disorder Database Study

Who this might be right for
Major Depressive Disorder
AstraZeneca 2,260
Early research (Phase 1)Study completedNCT02800577
What this trial is testing

Using Computer Tasks to Predict Response to Antidepressants

Who this might be right for
Depression
P1vital Products Limited 80
Not applicableUnknownNCT02857036
What this trial is testing

Rhythm and Depression

Who this might be right for
Depression
Centre Hospitalier Universitaire de Besancon 80
Not applicableNot Yet RecruitingNCT07611487
What this trial is testing

Multimodal MRI Study of Acupuncture's Rapid Antidepressant Mechanisms and Response Prediction in Depression

Who this might be right for
Major Depressive Disorder
Second Affiliated Hospital of Tsinghua University 80
Testing effectiveness (Phase 2)Study completedNCT02805439
What this trial is testing

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
Institut de Recherches Internationales Servier 400
Large-scale testing (Phase 3)Study completedNCT02085135
What this trial is testing

Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 66
Large-scale testing (Phase 3)Study completedNCT01197508
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

Who this might be right for
Major Depressive Disorder
AstraZeneca 696
Post-approval studies (Phase 4)Study completedNCT01477268
What this trial is testing

Cognitive Correlates of Antidepressant Treatment Response in Elders

Who this might be right for
Depression
Unity Health Toronto 30
Not applicableEnded earlyNCT01579942
What this trial is testing

Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 70
Post-approval studies (Phase 4)Study completedNCT00200902
What this trial is testing

Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression

Who this might be right for
Depression
University of California, Los Angeles 88
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation